1. Transgenic overexpression of the beta(2)-adrenergic receptor (beta(2)AR)
in mouse heart augments baseline cardiac function in a ligand-independent
manner, due to the presence of spontaneously active beta(2)AR (beta(2)AR*).
This study aims to elucidate the mechanism of beta(2)AR*-mediated modulati
on of cardiac excitation-contraction (EC) coupling.
2. Confocal imaging was used to analyse Ca2+ sparks and spatially resolve C
a2+ transients in single ventricular myocytes from transgenic (TG4) and non
-transgenic (NTG) littermates. Whole-cell voltage- and current-clamp techni
ques were used to record L-type Ca2+ currents (I-Ca) and action potentials,
respectively.
3. In the absence of any beta(2)AR ligand, TG4 myocytes had greater contrac
tion amplitudes, larger Ca2+ transients and faster relaxation times than di
d NTG cells.
4. The action potentials of TG4 and NTG myocytes were similar, except for a
prolonged end-stage repolarization in TG4 cells; the I-Ca density and kine
tics were nearly identical. The relationship between peak Ca2+ and contract
ion, which reflects myofilament Ca2+ sensitivity, was similar.
5. In TG4 cells, the frequency of Ca2+ sparks (spontaneous or evoked at -40
mV) was 2-7 times greater, despite the absence of change in the resting Ca
2+, sarcoplasmic reticulum (SR) Ca2+ content, and I-Ca. Individual sparks w
ere brighter, broader and lasted longer, leading to a 2.3-fold greater sign
al mass. Thus, changes in both spark frequency and size underlie the greate
r Ca2+ transient in TG4 cells.
6. The inverse agonist ICI 118,551 (ICI, 5 x 10(-7) M), which blocks sponta
neous beta(2)AR activation, reversed the aforementioned beta(2)AR* effects
on cardiac EC coupling without affecting the sarcolemmal I-Ca. However, ICI
failed to detect significant constitutive beta(2)AR activity in NTG cells.
7. We conclude that beta(2)AR*-mediated signalling enhances SR release chan
nel activity and Ca2+-induced Ca2+ release in TG4 cardiac myocytes, and tha
t beta(2)AR* enhances EC coupling by reinforcing SR Ca2+ cycling (release a
nd reuptake), but bypassing the sarcolemmal I-Ca.